Holen Sie sich die Stockscreener-App
1.22
10.91%
0.12
Handel nachbörslich:
1.25
0.03
+2.46%
Schlusskurs vom Vortag:
$1.10
Offen:
$1.1
24-Stunden-Volumen:
467.10K
Relative Volume:
2.82
Marktkapitalisierung:
$44.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.16M
KGV:
-2.1404
EPS:
-0.57
Netto-Cashflow:
$-8.75M
1W Leistung:
+1.67%
1M Leistung:
-5.06%
6M Leistung:
+18.45%
1J Leistung:
+5.17%
1-Tages-Spanne:
$1.10
$1.37
1-Wochen-Bereich:
$1.10
$1.37
52-Wochen-Spanne:
$0.75
$1.6899
Renovorx Inc Stock (RNXT) Company Profile
Firmenname
Renovorx Inc
Sektor
Branche
Telefon
408-800-2649
Adresse
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Vergleichen Sie RNXT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.22 | 40.23M | 0 | -9.16M | -8.75M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovorx Inc Aktie (RNXT) Neueste Nachrichten
Will RenovoRx Inc. continue its uptrendJuly 2025 Institutional & High Conviction Buy Zone Picks - Newser
Can swing trading help recover from RenovoRx Inc. lossesMarket Movers & AI Enhanced Execution Alerts - Newser
Will RenovoRx Inc. continue its uptrend [Market Performance Recap]Community Trade Idea Sharing - Newser
RenovoRx Inc. Testing Reversal Zone on Weekly ChartLong Hold Safe Return Strategy Reviewed - 선데이타임즈
Can trapped investors hope for a rebound in RenovoRx Inc.Product Launch & Daily Entry Point Alerts - Newser
What data driven models say about RenovoRx Inc.’s futureFree News Based Entry Opportunity Alerts - Newser
Is RenovoRx Inc. stock bottoming outNear-Term Market Opportunity Forecast Sheet - Newser
What makes RenovoRx Inc. stock price move sharplyMarket Movement Recap & Community Supported Trade Ideas - Newser
Visual trend scoring systems applied to RenovoRx Inc.Intelligent Trade Forecast With AI Analytics - Newser
What the charts say about RenovoRx Inc. todayFree Daily Chart Pattern Stock Forecast - Newser
Using Ichimoku Cloud for RenovoRx Inc. technicalsTrend Confirmation Scanner with Entry Focus - Newser
How RenovoRx Inc. stock performs during market volatilityDaily Market Movers Screener with Filters - Newser
What indicators show strength in RenovoRx Inc.Predictive Analytics for Equity Growth Potential - Newser
Is RenovoRx Inc. stock heavily shortedPower Growth Investing List - 뉴스임팩트
Can RenovoRx Inc. outperform in the next rallyTop Earnings Growth Momentum Picks - kangso.co.kr
RenovoRx Inc. stock momentum explainedMomentum Stocks with Breakout Potential - Newser
RenovoRx RNXT Q2 2025 Earnings Preview Upside Anticipated Amid Clinical Trial Developments - AInvest
RenovoRx Initiates Multi-Center Registry Study for RenovoCath Device - Medical Product Outsourcing
RenovoRx, Inc.'s (NASDAQ:RNXT) Shift From Loss To Profit - Yahoo Finance
Why RenovoRx Inc. stock attracts strong analyst attentionFree Weekly Hot Picks With Buy Confidence - Newser
Volume spikes in RenovoRx Inc. stock – what they meanFree Trade Setups With Clear Risk Limits - Newser
Signal strength of RenovoRx Inc. stock in tech scannersFree Accurate Buy Point for Momentum Stocks - Newser
Is RenovoRx Inc. trending in predictive chart modelsFree Momentum Based Equity Trading Plan - Newser
Is this a good reentry point in RenovoRx Inc.Triple Digit Gain Opportunity Watchlist - Newser
Will RenovoRx Inc. price bounce be sustainableDaily Pattern Analysis with Return Forecast - Newser
Why did RNXT's EPS remain flat throughout 2023? - AInvest
RenovoRx Inc. Breakout Confirmed by Volume MetricsGrowth Based Investment Plan Guidance Highlighted - beatles.ru
Heatmap analysis for RenovoRx Inc. and competitorsWeekly Market Direction and Sector Summary - Newser
Earnings Preview: RenovoRx to Report Financial Results Post-market on August 14 - 富途牛牛
RenovoRx CEO Finds Disconnect with Wall Street, Sees Undervalued Shares - AInvest
RenovoRx CEO Shaun Bagai on Targeted Oncology Therapies, Commercialization Progress, and Phase III TIGeR-PaC Clinical Trial. - AInvest
Meet RenovoRx: Fly exclusive interview with CEO Shaun Bagai - TipRanks
RenovoRx (RNXT) to Release Quarterly Earnings on Thursday - Defense World
RenovoRx expands commercial footprint to 13 cancer centers By Investing.com - Investing.com Canada
RenovoRx expands commercial footprint to 13 cancer centers - Investing.com
Finanzdaten der Renovorx Inc-Aktie (RNXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):